USPTO Examiner GUPTA ANANT AGUILAR - Art Unit 3792

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
18908199DEFIBRILLATION ASSEMBLY ENERGIZABLE THROUGH CASE OPENINGOctober 2024April 2025Allow710NoNo
18679350IMPLANTABLE ENDOVASCULAR, LOW PROFILE INTRACARDIAC LEFT ATRIAL RESTRAINING DEVICES FOR LOW ENERGY ATRIAL CARDIOVERSION, PACING AND SENSINGMay 2024April 2025Allow1120YesNo
18677663TISSUE COMPRESSION ANCHORSMay 2024June 2025Allow1210YesNo
18646403ADJUSTMENT OF ANALGESIC STIMULATION PARAMETERS BASED ON TRUST DYNAMIC MEASUREMENTSApril 2024February 2025Allow1010YesNo
18410888NON-BAROMETRIC DETERMINATION OF HEMODYNAMIC EFFECTS OF CARDIAC ARRHYTHMIAS USING SIGNALS SENSED BY AN IMPLANTABLE DEVICEJanuary 2024March 2025Allow1410NoNo
18540012Arrays for Delivering Tumor Treating Fields (TTFields) with Individually Accessible Electrode Elements and Temperature SensorsDecember 2023June 2025Allow1801YesNo
18499927DEVICES AND METHODS FOR IMPROVING HEADACHE DISORDERSNovember 2023February 2025Abandon1510NoNo
18385523ECG-BASED CARDIAC EJECTION-FRACTION SCREENINGOctober 2023September 2024Allow1020YesNo
18381024SYSTEM AND METHOD FOR LASER BASED TREATMENT OF SOFT TISSUEOctober 2023June 2024Allow800NoNo
18484999IMPLANTABLE NERVE STIMULATION DEVICEOctober 2023February 2024Allow410NoNo
18376726INSTRUMENT FLUSHING SYSTEMOctober 2023October 2024Allow1310YesNo
18238701SYSTEMS AND METHODS TO LOCATE AN IMPLANTABLE STIMULATOR DEVICE INSIDE A SUBJECTAugust 2023February 2025Allow1720NoNo
18232708ADAPTIVE CHRONIC PAIN RELIEF VIA IMPLANTED ELECTRICAL NEUROSTIMULATIONAugust 2023March 2025Allow1930YesNo
18447039DEVICE, SYSTEMS AND METHODS FOR TREATMENT OF NEUROGENIC BLADDERAugust 2023June 2024Allow1110NoNo
18218951ADJUSTMENT OF ANALGESIC STIMULATION PARAMETERS BASED ON TRUST DYNAMIC MEASUREMENTSJuly 2023January 2024Allow700NoNo
18213964Treatment of Acute Medical ConditionsJune 2023January 2024Allow700YesNo
18330755Automatic Determination of Inputs for Closed-Loop Algorithms for Optimization of Stimulation ParametersJune 2023October 2024Allow1730YesNo
18313289DEVICES AND METHODS FOR TREATMENT OF VENTILATOR ASSOCIATED DYSPHAGIAMay 2023June 2025Allow2600NoNo
18093049HYBRID POWERING SYSTEM FOR AN IMPLANTED MEDICAL DEVICEJanuary 2023December 2024Abandon2430NoNo
18077668LEAD FIXATION DEVICES FOR SECURING A LEAD TO A CRANIUMDecember 2022June 2025Allow3010NoNo
17926010SINGLE OR MULTIPLE NERVE STIMULATION TO TREAT SLEEP DISORDERED BREATHINGNovember 2022May 2025Allow3010NoNo
18053200ECG-BASED CARDIAC EJECTION-FRACTION SCREENINGNovember 2022July 2024Allow2130YesNo
17980058INSTRUMENT FLUSHING SYSTEMNovember 2022July 2023Allow810NoNo
17937100METHOD AND SYSTEM FOR APPLYING TUMOR TREATING FIELDS INTERFACING WITH HAIR FOLLICLESSeptember 2022June 2025Allow3300NoNo
17896710SYSTEM AND METHOD FOR LASER BASED TREATMENT OF SOFT TISSUEAugust 2022July 2023Allow1110NoNo
17881800HANDHELD MEDICAL INTERFACE FOR INTRALUMINAL DEVICE AND ASSOCIATED DEVICES, SYSTEMS, AND METHODSAugust 2022June 2023Allow1010NoNo
17872829Treatment of Acute Medical ConditionsJuly 2022March 2023Allow810NoNo
17857229DELIVERY DEVICE HAVING A DEFLECTABLE AND PEELABLE MAPPING GUIDE SHEATH FOR HIS BUNDLE PACINGJuly 2022July 2024Allow2400NoNo
17847671ADAPTIVE CHRONIC PAIN RELIEF VIA IMPLANTED ELECTRICAL NEUROSTIMULATIONJune 2022June 2023Allow1210NoNo
17842889ARTICULATED TOOL POSITIONER AND SYSTEM EMPLOYING SAMEJune 2022June 2025Allow3610NoNo
17664412SURGICAL INSTRUMENT WITH INCREASED ACTUATION FORCEMay 2022November 2023Allow1810YesNo
17744952SYSTEMS AND METHODS TO LOCATE AN IMPLANTABLE STIMULATOR DEVICE INSIDE A SUBJECTMay 2022April 2023Allow1110NoNo
17735417DEVICE AND METHOD FOR CUTTING A CORNEA OR A CRYSTALLINE LENSMay 2022June 2024Abandon2630NoNo
17661705IMPLANTABLE STIMULATION POWER RECEIVER, SYSTEMS AND METHODSMay 2022May 2024Abandon2420YesNo
17661336THERMALLY ROBUST LASER PROBE ASSEMBLYApril 2022April 2023Allow1110NoNo
17769965BIOLOGICAL ELECTRODE AND CARDIAC PACEMAKERApril 2022April 2025Allow3620NoNo
17721567SYSTEMS, METHODS, AND INTERFACES FOR USE IN CARDIAC EVALUATIONApril 2022March 2025Allow3501NoNo
17680017SYSTEM AND METHOD FOR AUTOFOCUSING OF A CAMERA ASSEMBLY OF A SURGICAL ROBOTIC SYSTEMFebruary 2022March 2025Allow3720YesNo
17670731Arrays for Delivering Tumor Treating Fields (TTFields) with Sets of Electrode Elements Having Individually Adjustable Active AreasFebruary 2022April 2025Allow3801NoNo
17650492Neural Feedback Assisted DBSFebruary 2022April 2024Allow2620NoNo
17634066DETECTION OF A POSITIONING STATE OF AN ELECTRODE LEAD DURING A LEAD INSERTION PROCEDUREFebruary 2022January 2025Allow3620NoNo
17591101MEDICAL SYSTEM FOR TREATING A LEFT ATRIAL APPENDAGEFebruary 2022April 2025Allow3820NoNo
17536351ADJUSTMENT OF ANALGESIC STIMULATION PARAMETERS BASED ON TRUST DYNAMIC MEASUREMENTSNovember 2021April 2023Allow1610YesNo
17534675MAPPING ECG SIGNALS USING A MULTIPOLE ELECTRODE ASSEMBLYNovember 2021February 2023Allow1550YesNo
17534004METHOD TO MANUFACTURE CUFF LEADSNovember 2021October 2024Allow3510NoNo
17454693BAYESIAN FRAMEWORK FOR PERSONALIZED MODEL IDENTIFICATION AND PREDICTION OF FUTURE BLOOD GLUCOSE IN TYPE 1 DIABETES USING EASILY ACCESSIBLE PATIENT DATANovember 2021May 2025Allow4230YesNo
17453192Flexible Sweat-Activated Graphene-Coated Ni foam-based Mg-O2 Battery for Stretchable Microelectronics for Continuous Biomarker MonitoringNovember 2021February 2025Allow3900NoNo
17504163INTRAVASCULAR FLUID MOVEMENT DEVICES, SYSTEMS, AND METHODS OF USEOctober 2021March 2023Allow1710YesNo
17483609WEARABLE CARDIOVERTER DEFIBRILLATOR SYSTEM WITH REMOTE ALERTS BASED ON PROXIMITYSeptember 2021June 2024Allow3320NoNo
17435906NEUROFEEDBACK AND INDUCTION OF AN IMMUNE RESPONSESeptember 2021July 2024Allow3410NoNo
17407201SYSTEM, METHOD, AND APPARATUS FOR APPLYING TRANSCUTANEOUS ELECTRICAL STIMULATIONAugust 2021October 2022Allow1400YesNo
17403910ELECTRODE ARRAY AND BODY-IMPLANTABLE DEVICE INCLUDING THE SAMEAugust 2021November 2024Allow3911NoNo
17372854IMPLANTABLE MEDICAL DEVICE AND ELECTRODE THEREOFJuly 2021October 2024Allow3920NoNo
17373405HERMETIC SEAL TESTER FOR MEDICAL DEVICES AND PROCESS FOR TESTING MEDICAL DEVICE INTEGRITY WITH A HERMETIC SEAL TESTERJuly 2021February 2025Allow4420NoNo
17370757APPARATUS FOR TESTING A CARDIAC CATHETER UTILIZING LIVE CARDIAC CELLSJuly 2021December 2024Allow4120NoNo
17363435Apparatus for Working on Eye Tissue By Means of a Pulsed Laser BeamJune 2021October 2022Allow1500YesNo
17309685METHOD FOR MANUFACTURING AN ELECTRODE ARRAY FOR A NEUROPROSTHETIC DEVICEJune 2021May 2025Abandon4711NoNo
17345128CORONARY ARTERY DISEASE DETECTION SIGNAL PROCESSING SYSTEMJune 2021March 2024Abandon3311YesNo
17345161CORONARY ARTERY DISEASE DETECTION SIGNAL PROCESSING SYSTEM AND METHODJune 2021March 2024Abandon3320YesNo
17293649IMPLANTING SYSTEM FOR IMPLANTING A TOTALLY IMPLANTABLE DEVICE IN A HUMAN OR ANIMAL BODYMay 2021August 2024Abandon3910NoNo
17306498INSTRUMENT FLUSHING SYSTEMMay 2021August 2022Allow1500YesNo
17245340ROBOTIC SURGICAL SYSTEM WITH ARTICULATION LOCKOUTApril 2021September 2024Abandon4011NoNo
17242533ARTIFICIAL VISION SYSTEMApril 2021September 2024Abandon4120NoNo
17285407SUPERVISOR FOR IMPLANTABLE STIMULATION DEVICESApril 2021May 2024Allow3710NoNo
17219510VENTRICULAR ASSIST SYSTEM AND METHODMarch 2021September 2022Allow1810YesNo
17185624CONTROLLING ELECTRICAL STIMULATION BASED ON A SENSED STIMULATION SIGNALFebruary 2021June 2024Allow4031YesNo
17271307SEPARATE PRINTED TRACES FOR ECG AND DEFIBRILLATION CIRCUITSFebruary 2021March 2024Allow3640NoNo
17271039A NEUROPROSTHETIC SYSTEM AND METHOD FOR SUBSTITUTING A SENSORY MODALITY OF A MAMMAL BY HIGH-DENSITY ELECTRICAL STIMULATION OF A REGION OF THE CEREBRAL CORTEXFebruary 2021October 2024Allow4441NoNo
17173792SYSTEM AND METHOD FOR LASER BASED TREATMENT OF SOFT TISSUEFebruary 2021August 2022Allow1810NoNo
17171773IMPLANTABLE MEDICAL SYSTEMS AND METHODS FOR USE THEREWITH THAT DETECT ATRIAL CAPTURE AND AV NODE CAPTURE RESPONSIVE TO HIS BUNDLE PACINGFebruary 2021May 2023Allow2710YesNo
17164686MONITORING METHOD OF HEART RATE FOR TOXICITY TEST USING HIGH-SPEED DIGITAL HOLOGRAPHYFebruary 2021February 2024Allow3610NoNo
17155394ASSEMBLIES CONTAINING TWO CONDUCTIVE GEL COMPOSITIONS AND METHODS OF PRODUCTION AND USE THEREOFJanuary 2021June 2022Allow1710NoNo
17139447ECG MONITOR DEVICE WITH ELECTRODE PADDecember 2020April 2025Allow5250NoNo
17137110Automatic Determination of Inputs for Closed-Loop Algorithms for Optimization of Stimulation ParametersDecember 2020March 2023Allow2620YesNo
17136710BURR CAP-MOUNTED ELECTRODESDecember 2020December 2022Allow2420NoNo
17256997UNIFORM MAPPING BALLOONDecember 2020May 2024Allow4020YesNo
17129088Arrays for Delivering Tumor Treating Fields (TTFields) with Individually Accessible Electrode Elements and Temperature SensorsDecember 2020December 2023Allow3511NoNo
17128123SYSTEM AND METHOD FOR GASTRIC ELECTRICAL STIMULATION USING COMPOUND NERVE ACTION POTENTIAL FEEDBACKDecember 2020August 2022Allow2000NoNo
17253262APPARATUS AND METHOD FOR DISTINGUISHING WIDE COMPLEX HEART BEATSDecember 2020August 2024Abandon4420NoNo
16973788SYSTEM AND DEVICE FOR DIAGNOSING AND MANAGING ERECTILE DYSFUNCTIONDecember 2020July 2024Abandon4301NoNo
17110904METHOD AND DEVICE FOR PROCESSING A CARDIAC SIGNALDecember 2020February 2024Allow3840YesNo
17058611STIMULATION APPARATUS AND STIMULATION METHOD USING SAMENovember 2020September 2023Allow3431NoNo
17099862Face Lifting DeviceNovember 2020June 2022Abandon1910NoNo
17091469SYSTEMS AND METHODS FOR OPTIMIZED WAVEFORM GENERATIONNovember 2020June 2024Allow4340YesNo
17068363HYBRID POWERING SYSTEM FOR AN IMPLANTED MEDICAL DEVICEOctober 2020January 2023Abandon2710NoNo
17046677SIMULTANEOUS MULTI-SITE VAGUS NERVE NEUROMODULATION FOR IMPROVED GLYCEMIC CONTROL SYSTEM AND METHODSOctober 2020February 2025Allow5240NoYes
17065269DEVICES AND METHODS FOR IMPROVING HEADACHE DISORDERSOctober 2020November 2023Abandon3720NoYes
17064800MOUTHPIECE FOR SKIN TREATMENT AND APPARATUS FOR SKIN TREATMENT USING ELECTRICAL ENERGYOctober 2020December 2022Allow2620YesNo
17044711USER INTERFACE FOR TITRATION ASSISTOctober 2020May 2025Allow5630YesNo
17036425METHOD FOR USING SOFT PHYSIOTHERAPY INSTRUMENTSeptember 2020July 2022Allow2220NoNo
17032631SURGICAL INSTRUMENT WITH INCREASED ACTUATION FORCESeptember 2020January 2022Allow1610NoNo
17005622Delivering Tumor Treating Fields (TTFields) to the NeckAugust 2020December 2023Allow3930NoNo
16993991SYSTEM AND METHOD FOR LASER BASED TREATMENT OF SOFT TISSUEAugust 2020January 2021Allow510YesNo
16991423ARTICULATED TOOL POSITIONER AND SYSTEM EMPLOYING SAMEAugust 2020May 2023Allow3420NoNo
16955331TREATMENT OF ACUTE MEDICAL CONDITIONSJune 2020April 2022Allow2220YesNo
16878740Rate Responsive PacingMay 2020March 2023Allow3440YesNo
16764349MASTER CONTROL DEVICE WITH MULTI-FINGER GRIP AND METHODS THEREFORMay 2020May 2025Allow6031YesNo
16865541IMPLANTABLE STIMULATION POWER RECEIVER, SYSTEMS AND METHODSMay 2020January 2022Allow2140NoNo
16754007ECG-BASED CARDIAC EJECTION-FRACTION SCREENINGApril 2020June 2024Allow5050YesNo
16652692MODIFIED NERVE CUFF ELECTRODE DESIGN FOR STABLE RECORDING AND/OR STIMULATIONApril 2020December 2023Allow4541NoNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner GUPTA, ANANT AGUILAR.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
4
Examiner Affirmed
4
(100.0%)
Examiner Reversed
0
(0.0%)
Reversal Percentile
19.6%
Lower than average

What This Means

With a 0.0% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is in the bottom 25% across the USPTO, indicating that appeals face significant challenges here.

Strategic Value of Filing an Appeal

Total Appeal Filings
11
Allowed After Appeal Filing
3
(27.3%)
Not Allowed After Appeal Filing
8
(72.7%)
Filing Benefit Percentile
37.3%
Lower than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 27.3% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is below the USPTO average, suggesting that filing an appeal has limited effectiveness in prompting favorable reconsideration.

Strategic Recommendations

Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.

Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.

Examiner GUPTA, ANANT AGUILAR - Prosecution Strategy Guide

Executive Summary

Examiner GUPTA, ANANT AGUILAR works in Art Unit 3792 and has examined 183 patent applications in our dataset. With an allowance rate of 71.6%, this examiner has a below-average tendency to allow applications. Applications typically reach final disposition in approximately 34 months.

Allowance Patterns

Examiner GUPTA, ANANT AGUILAR's allowance rate of 71.6% places them in the 26% percentile among all USPTO examiners. This examiner has a below-average tendency to allow applications.

Office Action Patterns

On average, applications examined by GUPTA, ANANT AGUILAR receive 2.42 office actions before reaching final disposition. This places the examiner in the 83% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by GUPTA, ANANT AGUILAR is 34 months. This places the examiner in the 26% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.

Interview Effectiveness

Conducting an examiner interview provides a +16.7% benefit to allowance rate for applications examined by GUPTA, ANANT AGUILAR. This interview benefit is in the 62% percentile among all examiners. Recommendation: Interviews provide an above-average benefit with this examiner and are worth considering.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 20.2% of applications are subsequently allowed. This success rate is in the 14% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 34.0% of cases where such amendments are filed. This entry rate is in the 43% percentile among all examiners. Strategic Recommendation: This examiner shows below-average receptiveness to after-final amendments. You may need to file an RCE or appeal rather than relying on after-final amendment entry.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 150.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 90% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences are highly effective with this examiner compared to others. Before filing a full appeal brief, strongly consider requesting a PAC. The PAC provides an opportunity for the examiner and supervisory personnel to reconsider the rejection before the case proceeds to the PTAB.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 60.0% of appeals filed. This is in the 32% percentile among all examiners. Of these withdrawals, 50.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows below-average willingness to reconsider rejections during appeals. Be prepared to fully prosecute appeals if filed.

Petition Practice

When applicants file petitions regarding this examiner's actions, 30.8% are granted (fully or in part). This grant rate is in the 23% percentile among all examiners. Strategic Note: Petitions are rarely granted regarding this examiner's actions compared to other examiners. Ensure you have a strong procedural basis before filing a petition, as the Technology Center Director typically upholds this examiner's decisions.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 44% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 9.2% of allowed cases (in the 87% percentile). Per MPEP § 714.14, a Quayle action indicates that all claims are allowable but formal matters remain. This examiner frequently uses Quayle actions compared to other examiners, which is a positive indicator that once substantive issues are resolved, allowance follows quickly.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Expect multiple rounds of prosecution: This examiner issues more office actions than average. Address potential issues proactively in your initial response and consider requesting an interview early in prosecution.
  • Request pre-appeal conferences: PACs are highly effective with this examiner. Before filing a full appeal brief, request a PAC to potentially resolve issues without full PTAB review.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.